Deep Intelligence Across Industries

Company Headquarters: England, UK Founded: 1990 Workforce: ~50 Company Working: BHR Pharmaceuticals Ltd is a fastest growing point of care diagnostic company which is involved in development medical devices. The company specialize in hematology, health equipment, immunology, point of care testing equipment, allergy testing supplies, migraine device, drug tests, and female health. Moreover, the company offers most technically advanced products and solutions to diagnose and treat as well as manage most prevalent diseases. The company has strong business presence in UK.

Company Headquarters: Massachusetts, US Founded: 2012 Workforce: <25 Company Working: Nivarta, Inc is fastest growing biotechnology company which developing therapeutics to treat metabolic conditions such as rare fat disorders, and dermatological disease. The company developing non-surgical treatment options which is based on protein therapeutics and small molecule drugs that create the anti-obesity and anti-diabetes effect of metabolic surgery. Moreover, the company have 4 targets in pre-clinical stage for diabetes, dercum 's disease, NAFL/NASH indications. The company has business presence in US.

Company Headquarters: Hamerkaz, Israel Founded: 2012 Workforce: ~10 Company Working: Raziel Therapeutics Ltd is a clinical-stage pharmaceutical company which is developing injectable therapeutics for the treatment of aesthetics and a variety of fat disorders. The company provide a single injection treatment into subcutaneous fat which is cause fast fat cell death at injection site as well as empowering medical professionals to enable patients with a better treatment fat reduction for long time periods without noninvasive procedure. The company has strong business presence in Israel.

Company Headquarters: New Taipei City, Taiwan Founded: 2012 Workforce: <25 Company Working: Caliway is a clinical stage biopharmaceutical company which is involved in development of innovative therapeutics in the treatment of obesity and anti-aging disorders. The company developing small molecule for non-surgical fat reduction, Dercum’s disease, cellulite, lipoma, osteoarthritis, and others. Moreover, the company pipeline molecule CBL-514, is a first-in-class new drug which can activate adipocyte apoptosis at the injection site and efficiently reduce the subcutaneous fat without any serious side effects. The company has strong business presence in Taiwan.

Company Headquarters: Beijing, China Founded: 2015 Workforce: ~300 Company Working: Jacobio Pharmaceuticals Group Co., Ltd. is a biotechnology company that develops and sells autoimmune drugs, cancer drugs, infectious disease drugs, and other products. It has R&D centers in Shanghai, China, and the US. The company manufactures and markets its products throughout China. It is also making partnerships with other players for R&D programs to develop innovative medicines.

Company Headquarters: Beijing, China Founded: 2002 Workforce: ~50 Company Working: Beijing Shenzhou Cell Biotechnology Group Co., Ltd. is a biopharmaceutical and vaccine research and development company. The company has a production facility at the Beijing Economic and Technological Development Zone that is cGMP-certified. It operates a subsidiary, China Cell Engineering Co., Ltd. The company also has a strong workforce of renown experts in biopharmaceutical R&D.

Company Headquarters: Washington, US Founded: 1997 Workforce: ~ 2,700 Company Working: Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. It offers antibody-drug conjugates (ADCs), including Padcevtm (enfortumab vedotin-ejfv), which is used to treat metastatic urothelial cancers, Adcetris (brentuximab vedotin), which is used to treat Hodgkin's lymphoma, T-cell lymphomas, and CD30-expressing lymphomas. (Tucat) Tukysa. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Additionally, Seagen also licenses its antibody-drug conjugate technology to several biotechnology and pharmaceutical companies. Seagen serves customers on a global scale.

Company Headquarters: Nanjing, China Founded: 1969 Workforce: ~ 1,800 Company Working: Chia Tai Tianqing Pharmaceutical Group Co. produces and manufactures pharmaceutical products. The company sells drugs for diseases like diabetes, liver disease, cancer, cardiovascular disease, anti-infective, digestion problems, and respiratory problems. Chia Tai Tianqing Pharmaceutical Group distributes its products domestically and internationally. With GMP-based clearance from the US FDA and EU Health Authority, as well as specialized and diversified products in development, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), one of the top 30 pharmaceutical companies in China, anticipates being more active in foreign business. In addition, it operates s as a subsidiary of Sino Biopharmaceutical Limited. It has 3 manufacturing plants focusing on FDF and API production, 2 R&D centers, 1 overseas branch (CTTQ EU) in Barcelona, Spain, 1 business development office in San Diego, USA, and 4 joint labs (in Shanghai and Chengdu).

Company Headquarters: Minnesota, US Founded: 2009 Workforce: ~100 Company Working: HistoSonics, Inc. is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. The company’s new platform deliverers personalized, tissue-specific treatments with precision and control , and without the undesirable side effects of many of today's interventional and surgical modalities, allowing physicians to continuously monitor the treatment and its effect in real-time. HistoSonics is run by a group of knowledgeable industry leaders. HistoSonics, Inc. was established to further the advancement of histotripsy, a ground-breaking scientific discovery and development made by eminent researchers at the University of Michigan to give patients with better therapy.